Kumi Chemical has sharply raised its first-half outlook, but the upgrade comes with an asterisk. For the first half of the year ending October 2026, it now expects revenue of ¥102,900mn, operating profit of ¥10,400mn, ordinary profit of ¥13,700mn and net profit attributable to owners of parent of ¥8,700mn, all well above its December forecast. Management said the main drivers were pulled-forward shipments in its agrochemical and agriculture-related business, helped by sales promotion ahead of generic entry in the US for its main product, plus strong sales in the chemical products business.
| Metric | Previous forecast | Revised forecast | Prior interim actual |
|---|---|---|---|
| Revenue | ¥92,800mn | ¥102,900mn | ¥96,177mn |
| Operating profit | ¥6,100mn | ¥10,400mn | ¥9,442mn |
| Ordinary profit | ¥8,200mn | ¥13,700mn | ¥8,291mn |
| Net profit attributable to owners of parent | ¥4,400mn | ¥8,700mn | ¥6,274mn |
| Interim EPS | ¥36.54 | ¥72.24 | ¥52.11 |
That makes the upgrade more than a routine tidy-up, but not a pure demand story either. Kumi Chemical explicitly said some shipments were brought forward, and that those earlier shipments helped secure profit. Even so, the revised targets are above the prior interim actual on every major line the company disclosed, including revenue of ¥96,177mn, operating profit of ¥9,442mn, ordinary profit of ¥8,291mn and net profit of ¥6,274mn. Interim earnings per share are now forecast at ¥72.24, up from ¥36.54 previously and above the prior interim actual of ¥52.11.
Reported profit will still carry a below-the-line drag. In a separate notice, Kumi Chemical said it expects special losses in the February to April quarter at a consolidated subsidiary's chlorination business. Those include a ¥514mn impairment loss after the company reviewed recoverability under impairment accounting standards and concluded recoverable value had fallen below book value, plus a ¥907mn structural reform cost tied to a broader restructuring effort in what it described as a severe business environment.
The bigger uncertainty sits in the second half. Kumi Chemical left its full-year outlook unchanged, saying heightened tensions in the Middle East and a prolonged conflict could affect its business, but the scale of that impact is still being assessed. It also said any additional special losses that matter for earnings will be disclosed once confirmed. For readers, the message is straightforward: first-half operating momentum has improved sharply, but some of the boost is timing-related and reported profit is still being trimmed by impairment and restructuring charges.